TBI-RECOVER in Outpatient Substance Use Treatment
Official title: Facilitation as a Strategy for Implementing the Novel TBI-RECOVER Intervention Into Substance Use Treatment: A Mixed Methods Hybrid Type 2 Effectiveness-Implementation Trial
Run by Ohio State University · NCT07215221 · Data updated 2026-11-12
This trial tests whether the TBI-RECOVER program can help people with a substance use disorder who have a brain injury, by improving retention in treatment and managing cognitive and behavioral challenges.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 900 (estimated) |
| Sponsor | Ohio State University Academic / other |
| Locations | 1 site (Columbus, Ohio) |
| Status | Recruiting |
| Started | April 28, 2026 |
| Main results expected | January 30, 2030 |
| Study ends | March 30, 2030 |
| Registry record updated | July 7, 2026 |
| Trial ID | NCT07215221 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
English-speaking adults with a diagnosed substance use disorder receiving outpatient psychotherapy at participating OSU clinics.
✕Probably not a fit
Patients who do not have a substance use disorder, do not have a diagnosed brain injury, or are not receiving outpatient psychotherapy may not benefit from this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This hybrid type 2 pilot study examines both the implementation and the effectiveness of the TBI-RECOVER intervention within outpatient SUD treatment settings. It tests a bundle of strategies—training, champions, audit and feedback, and facilitation—to support providers in delivering brain injury and cognitive screening, along with neurocognitive accommodations. The goal is to see if these practices increase provider use and sustainment and, in turn, improve patient symptoms and treatment retention. The study is conducted within the Ohio State University system in Columbus, with NIDA as a collaborator. Eligible participants are English-speaking adults with SUD assigned to outpatient psychotherapy; all treatment providers at participating clinics may participate.
Why it matters
Potential benefit: If successful, patients may experience better symptom management and higher retention in outpatient substance use treatment.
How similar studies have gone: Previous work on implementation bundles and brain injury screening in SUD care suggests potential benefits, but this exact approach is being tested in a hybrid type 2 design.
Who can join: the full rules
Show full inclusion / exclusion criteria
Patient Inclusion Criteria: * English-speaking; diagnosed with a substance use disorder; assigned to an outpatient provider for psychotherapy at the treatment clinic participating in the study. Patient Exclusion Criteria: * None Provider Inclusion Criteria: \- All providers employed in the outpatient treatment clinic who deliver psychotherapy are eligible (e.g., social workers, counselors, psychologists).
Where it's running
-
OSU Hospital System
Columbus, Ohio, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
PIONEER-Prognosis: Using biomarkers and wearables to forecast recovery after mild traumatic brain injury
This study tests whether blood biomarkers, health data from records, and wearables can help predict how people recover after a mild traumatic brain injury treated in the emergency department.
-
HBOT to see if it helps cognition and well‑being in first responders with prior brain injury
This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.
-
Depth Electrode Monitoring after Traumatic Brain Injury
This study tests adding a depth electrode with continuous brain monitoring during external ventricular drain placement in adults with traumatic brain injury to see if cortical reverberation signals can be tracked safely.
-
Project SHIELD 2.0: Police Education to Support Public Health in Kentucky
Aimed at police in Kentucky, this program tests whether SHIELD training given to officers, with health workers helping deliver it, can reduce drug-related arrests and steer people who use drugs toward MOUD and other health services.
-
Understanding growth hormone deficiency after a brain injury in adults
This observational study tests whether growth hormone deficiency affects quality of life and symptoms in adults with traumatic brain injury and whether GH replacement helps after 12 weeks.
-
Electrical stimulation-assisted exercise for people with lower limb paralysis
This study tests whether adding electrical stimulation during exercise can improve leg muscle strength and endurance for people with paralysis.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.